Cost-Effectiveness of Cognitive Behavioural Therapy and Selective Serotonin Reuptake Inhibitors for Major Depression in Children and Adolescents
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective: To assess from a health sector perspective the incremental cost-effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) for the treatment of major depressive disorder (MDD) in children and adolescents, compared to ‘current practice’. Method: The health benefit is measured as a reduction in disability-adjusted life years (DALYs), based on effect size calculations from meta-analysis of randomised controlled trials. An assessment on second stage filter criteria (‘equity’; ‘strength of evidence’, ‘feasibility’ and ‘acceptability to stakeholders’) is also undertaken to incorporate additional factors that impact on resource allocation decisions. Costs and benefits are tracked for the duration of a new episode of MDD arising in eligible children (age 6–17 years) in the Australian population in the year 2000. Simulation-modelling techniques are used to present a 95% uncertainty interval (UI) around the cost-effectiveness ratios. Results: Compared to current practice, CBT by public psychologists is the most costeffective intervention for MDD in children and adolescents at A$9000 per DALY saved (95% UI A$3900 to A$24 000). SSRIs and CBT by other providers are less cost-effective but likely to be less than A$50 000 per DALY saved (< 80% chance). CBT is more effective than SSRIs in children and adolescents, resulting in a greater total health benefit (DALYs saved) than could be achieved with SSRIs. Issues that require attention for the CBT intervention include equity concerns, ensuring an adequate workforce, funding arrangements and acceptability to various stakeholders. Conclusions: Cognitive behavioural therapy provided by a public psychologist is the most effective and cost-effective option for the first-line treatment of MDD in children and adolescents. However, this option is not currently accessible by all patients and will require change in policy to allow more widespread uptake. It will also require ‘start-up’ costs and attention to ensuring an adequate workforce.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Major Depression in Community Adolescents: Age at Onset, Episode Duration, and Time to Recurrence
LEWINSOHN, P. M., CLARKE, G. N., SEELEY, J. R., & ROHDE, P. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199407000-00006 · Cited by 836
A meta-analysis of the effects of cognitive therapy in depressed patients
Gloaguen, V., Cottraux, J., Cucherat, M., & Blackburn, I.-M. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00199-7 · Cited by 809
Brent, D. A. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210125017 · Cited by 753 · cited 2×
“With CBT 62% of patients remitted by the end of treatment compared to 39% of the control groups [13–18].”
MethodResultKELLER, M. B., RYAN, N. D., STROBER, M., KLEIN, R. G., KUTCHER, S. P., BIRMAHER, B., HAGINO, O. R., KOPLEWICZ, H., CARLSON, G. A., CLARKE, G. N., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00010 · Cited by 641 · cited 2×
“For SSRIs four RCTs fitted the inclusion criteria [20–23].”
BackgroundCognitive-behavioral treatment for depressed adolescents
Lewinsohn, P. M., Clarke, G. N., Hops, H., & Andrews, J. (1990) · Behavior Therapy · doi:10.1016/s0005-7894(05)80353-3 · Cited by 612 · cited 2×
“With CBT 62% of patients remitted by the end of treatment compared to 39% of the control groups [13–18].”
MethodResultWood, A., Harrington, R., & Moore, A. (1996) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1996.tb01466.x · Cited by 295
Influence of Parental Concordance for Psychiatric Disorders on Psychopathology in Offspring
Dierker, L. C., Merikangas, K. R., & Szatmari, P. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199903000-00015 · Cited by 178
Cited by
The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses
Hofmann, S. G., Asnaani, A., Vonk, I. J. J., Sawyer, A. T., & Fang, A. (2012) · Cognitive Therapy and Research · doi:10.1007/s10608-012-9476-1 · Cited by 3,445
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Cost-Effectiveness of Treatments for Adolescent Depression: Results From TADS
Domino, M. E., Burns, B. J., Silva, S. G., Kratochvil, C. J., Vitiello, B., Reinecke, M. A., Mario, J., & March, J. S. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07101610 · Cited by 92
Stallard, P., Phillips, R., Montgomery, A., Spears, M., Anderson, R., Taylor, J., Araya, R., Lewis, G., Ukoumunne, O., Millings, A., et al. (2013) · Health Technology Assessment · doi:10.3310/hta17470 · Cited by 87
“In contrast, an earlier modelling-based cost-effectiveness study in Australia, comparing individual CBT with ‘current practice’ to treat major depression in children and adolescents (aged 6–17 years), estimated that CBT saved disability-adjusted life-years (DALYs) at a cost of A$9000 per DALY saved.(68) Therefore, it…”
Result
Metadata
- Authors
- Haby, M. M., Tonge, B., Littlefield, L., Carter, R., & Vos, T.
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2004-08
- Volume
- 38
- Issue
- 8
- Pages
- 579-591
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2128113616
- Cited by
- 72
- References
- 8
- FWCI
- 15.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-Effectiveness of Cognitive Behavioural Therapy and Selective Serotonin Reuptake Inhibitors for Major Depression in Children and Adolescents. https://app.cochat.ai/papers/10.1080/j.1440-1614.2004.01421.x
- The paper
- Haby, M. M., Tonge, B., Littlefield, L., Carter, R., & Vos, T. (2004). Cost-Effectiveness of Cognitive Behavioural Therapy and Selective Serotonin Reuptake Inhibitors for Major Depression in Children and Adolescents. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1080/j.1440-1614.2004.01421.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.